KBC Group
INSM icon

KBC Group’s Insmed INSM Stock Holding History

KBC Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.67M Sell
34,421
-2,926
-8% -$354K 0.01% 567
2026
Q1 		$6.11M Buy
37,347
+3,334
+10% +$513K 0.02% 435
2025
Q4 		$5.92M Buy
34,013
+24,396
+254% +$4.45M 0.01% 437
2025
Q3 		$1.39M Buy
9,617
+4,641
+93% +$569K ﹤0.01% 647
2025
Q2 		$501K Sell
4,976
-2,575
-34% -$197K ﹤0.01% 708
2025
Q1 		$576K Buy
7,551
+678
+10% +$51.9K ﹤0.01% 706
2024
Q4 		$475K Buy
6,873
+2,563
+59% +$185K ﹤0.01% 819
2024
Q3 		$315K Buy
4,310
+730
+20% +$53.9K ﹤0.01% 783
2024
Q2 		$240K Buy
3,580
+405
+13% +$15.7K ﹤0.01% 813
2024
Q1 		$86K Hold
3,175
– – ﹤0.01% 1210
2023
Q4 		$98K Hold
3,175
– – ﹤0.01% 1074
2023
Q3 		$80K Buy
+3,175
New +$72.6K ﹤0.01% 1104

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

KBC Group's INSM Position: Q2 2026 in Review

KBC Group reduced its Insmed (INSM) stake by 7.8% in Q2 2026, selling an estimated $354K and leaving 34,421 shares worth $3.67M. The position accounts for 0.01% of the portfolio, ranked #567.

KBC Group first reported a position in INSM in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.11M in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • KBC Group held 34,421 shares of Insmed worth $3.67M as of Q2 2026.
  • KBC Group sold 2,926 Insmed shares in Q2 2026, an estimated $354K.
  • Insmed made up 0.01% of KBC Group's portfolio in Q2 2026, its #567 holding.
  • KBC Group first reported a position in Insmed in Q3 2023 and has held it in 12 quarters since.
  • KBC Group's Insmed position peaked at $6.11M in Q1 2026.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.